{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:43:27Z","timestamp":1697172207988},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,4,2]],"date-time":"2004-04-02T00:00:00Z","timestamp":1080864000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background.\u2002<\/jats:bold> Studies on eradication therapy in developing countries have shown a success rate of 70\u201385%, which is suboptimal. Duration of therapy may be an important factor dictating eradication success in such regions.<\/jats:p><jats:p><jats:bold>Aim.\u2002<\/jats:bold> The study was undertaken to evaluate the effect of increasing the treatment period on eradication of <jats:italic>Helicobacter pylori<\/jats:italic> in duodenal ulcer disease.<\/jats:p><jats:p><jats:bold>Methods.\u2002<\/jats:bold> A randomized trial was carried out in which 64 consecutive <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010infected patients with duodenal ulcer disease were enrolled. The patients were randomized to one of the three trial arms. Therapy consisted of lansoprazole 30\u00a0mg twice a day (b.i.d.), amoxycillin 1\u00a0g b.i.d. and tinidazole 500\u00a0mg b.i.d. The treatment period was 1\u00a0week in group I, 2\u00a0weeks in group II and 3\u00a0weeks in group III. At inclusion, patients underwent endoscopy and the presence of <jats:italic>H.\u00a0pylori<\/jats:italic> was documented by a positive urease test and C14 urea breath test. Four weeks after completion of eradication therapy, the patients were subjected to repeat endoscopy to assess ulcer healing and tests for <jats:italic>H.\u00a0pylori<\/jats:italic> infection.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> Sixty\u2010four patients (55 male and nine female; mean age\u00a035.5\u00a0years) were enrolled in each group. The <jats:italic>H.\u00a0pylori<\/jats:italic> eradication rate for group I (1\u00a0week of therapy) was 47.6%, that for group II (2\u00a0weeks of therapy) was 80%, and that for group III (3\u00a0weeks of therapy) was 91.3% (<jats:italic>p\u00a0=<\/jats:italic>\u00a0.003). The ulcer healing rates were 71.4, 80 and 95.6% in groups I, II and III, respectively (<jats:italic>p\u00a0=<\/jats:italic>\u00a0.09).<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold> The 3\u2010week regimen significantly improved the eradication rate as compared with the 1\u2010week regime. Increasing the duration of therapy significantly improved the chances of eradication of <jats:italic>H.\u00a0pylori<\/jats:italic> in duodenal ulcer disease.<\/jats:p>","DOI":"10.1111\/j.1083-4389.2004.00208.x","type":"journal-article","created":{"date-parts":[[2004,4,2]],"date-time":"2004-04-02T16:36:40Z","timestamp":1080923800000},"page":"124-129","source":"Crossref","is-referenced-by-count":11,"title":["Rank Order of Success Favors Longer Duration of Imidazole\u2010Based Therapy for <i>Helicobacter pylori<\/i> in Duodenal Ulcer Disease: A Randomized Pilot Study"],"prefix":"10.1111","volume":"9","author":[{"given":"Ashmit","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrasekhar S.","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder Mohan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh Prakash","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,2]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00542.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.111282000.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/11024159850191391"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2008.S61"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00330.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00338.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2000.00012.x"},{"issue":"1","key":"e_1_2_5_9_2","first-page":"S20","article-title":"In vitro sensitivity of Helicobacter pylori in India","volume":"16","author":"Abraham P","year":"1997","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_5_10_2","first-page":"23","article-title":"Metronidazole resistance in Helicobacter pylori: magnitude, mechanism and implications for India","volume":"21","author":"Chowdhury A","year":"2002","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00258-0"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2000.00030.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2747"},{"key":"e_1_2_5_14_2","first-page":"A95","article-title":"Seven vs fourteen days treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients","volume":"41","author":"Dammann HG","year":"1998","journal-title":"Gut"},{"issue":"1","key":"e_1_2_5_15_2","first-page":"A100","article-title":"Eradication of H. pylori with two triple therapy regimens of 7, 10 and 14 days duration","volume":"41","author":"Katicic M","year":"1998","journal-title":"Gut"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01396.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00839.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2001.01362.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.15.1651"},{"key":"e_1_2_5_20_2","first-page":"61","article-title":"Evaluation of endoscopy based diagnostic methods for the detection of Helicobacter pylori","volume":"19","author":"Saksena S","year":"2000","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_5_21_2","first-page":"330","article-title":"Can the C\u201014 urea breath test replace follow\u2010up endoscopic biopsies in patients treated for Helicobacter pylori infection?","volume":"18","author":"Ahuja V","year":"1998","journal-title":"Clin Nuclear Med"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35224"},{"key":"e_1_2_5_23_2","first-page":"103","article-title":"Peptic ulcer disease in the tropics: lessons from India","volume":"45","author":"Sharma MP","year":"2000","journal-title":"Ceylon Med J"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","unstructured":"BhatiaV AhujaV DasB BalCS SharmaMP.Use of imidazole based eradication regimes forHelicobacter pylorishould be abandoned in North India regardless of in vitro antibiotic sensitivity.J Gastroenterol Hepatol2004 in press.","DOI":"10.1111\/j.1440-1746.2003.03276.x"},{"key":"e_1_2_5_25_2","first-page":"191","article-title":"Randomized trial of a quadruple drug regimen and a triple drug regimen for eradication of H. pylori: a long term follow up study","volume":"20","author":"Kumar D","year":"2001","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00508.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005457226341"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1083-4389.2004.00208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1083-4389.2004.00208.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T15:58:16Z","timestamp":1697126296000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1083-4389.2004.00208.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1083-4389.2004.00208.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1083-4389.2004.00208.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}